Beeden Internation
⚠️ High Risk
FEI: 3004445737 • Mumbai • INDIA
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
COL ADDED
The article appears to bear or contain, for the purpose of coloring only, a color additive which is unsafe within the meaning of Section 721(a).
USUAL NAME
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(i)(1) of the FD&C Act in that the label fails to bear the common or usual name of the food, if any there be.
DR QUALITC
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the drug appears to be represented as not being recognized in an official compendium and appears its strength differs from or its quality or purity falls below, that which it purports or is represented to possess.
INCONSPICU
Information required by the Act to be on the label or labeling does not appear to be conspicuous enough as to render it likely to be read and understood by the ordinary individual under customary conditions of purchase and use.
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 4/13/2004 | 65LBJ99PROTECTANT N.E.C. | 336INCONSPICU | New Orleans District Office (NOL-DO) |
| 4/12/2004 | 66VCP99MISCELLANEOUS PATENT MEDICINES, ETC. | 331DR QUALITC | New Orleans District Office (NOL-DO) |
| 4/12/2004 | 28YGH99SPICES, FLAVORS AND SALT NOT MENTIONED ELSEWHERE, N.E.C. | 328USUAL NAME | New Orleans District Office (NOL-DO) |
| 4/12/2004 | 61PAA99ANTI-DIABETIC N.E.C. | 178COL ADDED | New Orleans District Office (NOL-DO) |
| 4/12/2004 | 54ABA90MULTIPLE VITAMINS (MVI-12 VITAMIN COMBO) (VITAMIN) | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 4/12/2004 | 62UAH99ANTI-TUSSIVE/COLD N.E.C. | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 4/12/2004 | 62UAH99ANTI-TUSSIVE/COLD N.E.C. | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 4/12/2004 | 62UAH99ANTI-TUSSIVE/COLD N.E.C. | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 4/12/2004 | 62CAA99ANTI-HYPERTENSIVE N.E.C. | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 4/12/2004 | 61PAA99ANTI-DIABETIC N.E.C. | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 4/12/2004 | 66VCP99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
Frequently Asked Questions
What is Beeden Internation's FDA import refusal history?
Beeden Internation (FEI: 3004445737) has 11 FDA import refusal record(s) in our database, spanning from 4/12/2004 to 4/13/2004.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Beeden Internation's FEI number is 3004445737.
What types of violations has Beeden Internation received?
Beeden Internation has been cited for 5 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Beeden Internation come from?
All FDA import refusal data for Beeden Internation is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.